Hearing status of thalassemic patients treated with dessfroxamin

AuthorMajid Ashrafien
AuthorAli Mohammadzadehen
Issued Date2012-01-20en
AbstractBackground: Major beta thalassemia is the most common inherited anemia with high prevalence in Iran and hearing loss is one of its side effects. The present study aimed to determine the hearing status of patients with major thalassemia and its relationship with serum ferritin level, period of blood transfusion and Dessfroxamin administration.en
DOIhttps://doi.org/en
Keywordhearing lossen
Keywordferritinen
Keywordthalassemia majoren
Keyworddesferalen
PublisherBrieflandsen
TitleHearing status of thalassemic patients treated with dessfroxaminen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
79024.pdf
Size:
241.01 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF